Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Acta Pharmaceutica
Volume 69 (2019): Numero 1 (March 2019)
Accesso libero
The antitumor activity of umbelliferone in human renal cell carcinoma
via
regulation of the p110γ catalytic subunit of PI3Kγ
Xue Wang
Xue Wang
,
Shuaishuai Huang
Shuaishuai Huang
,
Xia Xin
Xia Xin
,
Yu Ren
Yu Ren
,
Guobin Weng
Guobin Weng
e
Ping Wang
Ping Wang
| 07 dic 2018
Acta Pharmaceutica
Volume 69 (2019): Numero 1 (March 2019)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
07 dic 2018
Pagine:
111 - 119
Accettato:
18 ago 2018
DOI:
https://doi.org/10.2478/acph-2019-0004
Parole chiave
umbelliferone
,
renal cell carcinoma
,
p110γ
,
anti-cancer activity
© 2019 Xue Wang et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Xue Wang
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital,
Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University
Ningbo, China
Shuaishuai Huang
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital,
Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University
Ningbo, China
Xia Xin
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital,
Ningbo, China
Yu Ren
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital,
Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University
Ningbo, China
Guobin Weng
Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital,
Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University
Ningbo, China
Ping Wang
Ningbo University, School of Medicine
Ningbo, China